Synopsis
Synopsis
0
JDMF
0
VMF
0
Australia
Annual Reports
NA
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers


1. Dichlofenal
2. Diclofenac
3. Diclofenac Sodium
4. Diclofenac, Sodium
5. Diclonate P
6. Diclophenac
7. Dicrofenac
8. Feloran
9. Gp 45,840
10. Gp-45,840
11. Gp45,840
12. Novapirina
13. Orthofen
14. Orthophen
15. Ortofen
16. Sodium Diclofenac
17. Sr 38
18. Sr-38
19. Sr38
20. Voltaren
21. Voltarol
1. 15307-81-0
2. Cataflam
3. Cgp 45840b
4. Voltfast
5. Cambia
6. Zipsor
7. Diclofenac Potassium [usan:usp]
8. Potassium Diclofenac
9. Potassium;2-[2-(2,6-dichloroanilino)phenyl]acetate
10. Diclofenac (potassium)
11. Cgp-45840b
12. Diclofenac Potassium Salt
13. L4d5ua6cb4
14. Chebi:4508
15. Benzeneacetic Acid, 2-((2,6-dichlorophenyl)amino)-, Monopotassium Salt
16. Potassium 2-(2-((2,6-dichlorophenyl)amino)phenyl)acetate
17. Cataflam; Diclofenac Potassium; K-fenak; Potassium Diclofenac; Prosorb
18. Diclofenac Potassium [usan]
19. Unii-l4d5ua6cb4
20. Cataflam (tn)
21. Potassium (o-(2,6-dichloroanilino)phenyl)acetate
22. Cambia (tn)
23. Zipsor (tn)
24. Diclofenac Potassium (usp)
25. Schembl40784
26. Chembl1200804
27. Dtxsid30165212
28. Hms3656d18
29. Diclofenac Potassium [vandf]
30. Diclofenac Potassium [mart.]
31. S3062
32. Diclofenac Potassium [usp-rs]
33. Diclofenac Potassium [who-dd]
34. Akos015889752
35. Akos015994733
36. Diclofenac Potassium Salt [mi]
37. Ccg-267848
38. Ks-5037
39. Ac-18735
40. Diclofenac Potassium [orange Book]
41. Hy-15038
42. Diclofenac Potassium [ep Monograph]
43. Db-043176
44. Diclofenac Potassium [usp Monograph]
45. Cs-0003712
46. Ft-0603076
47. Sw196404-4
48. D00903
49. Q27106401
50. Potassium {2-[(2,6-dichlorophenyl)amino]phenyl}acetate
51. Potassium 2-(2-(2,6-dichlorophenylamino)phenyl)acetate
52. Potassium (o-((2,6-dichlorophenyl)amino)phenyl)acetate
53. 2-((2,6-dichlorophenyl)amino)benzeneacetic Acid, Monopotassium Salt
| Molecular Weight | 334.2 g/mol |
|---|---|
| Molecular Formula | C14H10Cl2KNO2 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 4 |
| Exact Mass | 332.9725654 g/mol |
| Monoisotopic Mass | 332.9725654 g/mol |
| Topological Polar Surface Area | 52.2 Ų |
| Heavy Atom Count | 20 |
| Formal Charge | 0 |
| Complexity | 310 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
| 1 of 8 | |
|---|---|
| Drug Name | Cambia |
| Drug Label | CAMBIA (Diclofenac Potassium for Oral Solution) is a benzeneacetic acid derivative NSAID. CAMBIA is available as a buffered soluble powder, designed to be mixed with water prior to oral administration. CAMBIA is a white to off-white, buff... |
| Active Ingredient | Diclofenac potassium |
| Dosage Form | For solution |
| Route | Oral |
| Strength | 50mg |
| Market Status | Prescription |
| Company | Depomed |
| 2 of 8 | |
|---|---|
| Drug Name | Cataflam |
| PubMed Health | Diclofenac |
| Drug Classes | Analgesic, Anti-Inflammatory, Antimigraine, Antirheumatic, Central Nervous System Agent, Musculoskeletal Agent, Ophthalmologic Agent |
| Drug Label | Cataflam (diclofenac potassium immediate-release tablets) is a benzeneacetic acid derivative. Cataflam is available as immediate-release tablets of 50 mg (light brown) for oral administration. The chemical name is 2-[(2,6-dichlorophenyl)amino] benz... |
| Active Ingredient | Diclofenac potassium |
| Dosage Form | Tablet |
| Route | Oral |
| Strength | 50mg |
| Market Status | Prescription |
| Company | Novartis |
| 3 of 8 | |
|---|---|
| Drug Name | Diclofenac potassium |
| Drug Label | Diclofenac potassium tablets USP are a benzeneacetic acid derivative. Diclofenac potassium tablets USP, 50 mg are available as orange, film-coated tablets for oral administration. The chemical name is 2-[(2,6-dichlorophenyl)amino] benzeneacetic acid,... |
| Active Ingredient | Diclofenac potassium |
| Dosage Form | Tablet |
| Route | Oral |
| Strength | 50mg |
| Market Status | Prescription |
| Company | Teva; Apotex; Sandoz; Mylan |
| 4 of 8 | |
|---|---|
| Drug Name | Zipsor |
| PubMed Health | Diclofenac |
| Drug Classes | Analgesic, Anti-Inflammatory, Antimigraine, Antirheumatic, Central Nervous System Agent, Musculoskeletal Agent, Ophthalmologic Agent |
| Drug Label | Zipsor (diclofenac potassium) Liquid Filled Capsule is a benzeneacetic acid derivative NSAID. Zipsor is available as liquid-filled capsules of 25 mg for oral administration. The chemical name is 2-[(2,6- dichlorophenyl) amino] benzeneacetic acid mono... |
| Active Ingredient | Diclofenac potassium |
| Dosage Form | Capsule |
| Route | Oral |
| Strength | 25mg |
| Market Status | Prescription |
| Company | Depomed |
| 5 of 8 | |
|---|---|
| Drug Name | Cambia |
| Drug Label | CAMBIA (Diclofenac Potassium for Oral Solution) is a benzeneacetic acid derivative NSAID. CAMBIA is available as a buffered soluble powder, designed to be mixed with water prior to oral administration. CAMBIA is a white to off-white, buff... |
| Active Ingredient | Diclofenac potassium |
| Dosage Form | For solution |
| Route | Oral |
| Strength | 50mg |
| Market Status | Prescription |
| Company | Depomed |
| 6 of 8 | |
|---|---|
| Drug Name | Cataflam |
| PubMed Health | Diclofenac |
| Drug Classes | Analgesic, Anti-Inflammatory, Antimigraine, Antirheumatic, Central Nervous System Agent, Musculoskeletal Agent, Ophthalmologic Agent |
| Drug Label | Cataflam (diclofenac potassium immediate-release tablets) is a benzeneacetic acid derivative. Cataflam is available as immediate-release tablets of 50 mg (light brown) for oral administration. The chemical name is 2-[(2,6-dichlorophenyl)amino] benz... |
| Active Ingredient | Diclofenac potassium |
| Dosage Form | Tablet |
| Route | Oral |
| Strength | 50mg |
| Market Status | Prescription |
| Company | Novartis |
| 7 of 8 | |
|---|---|
| Drug Name | Diclofenac potassium |
| Drug Label | Diclofenac potassium tablets USP are a benzeneacetic acid derivative. Diclofenac potassium tablets USP, 50 mg are available as orange, film-coated tablets for oral administration. The chemical name is 2-[(2,6-dichlorophenyl)amino] benzeneacetic acid,... |
| Active Ingredient | Diclofenac potassium |
| Dosage Form | Tablet |
| Route | Oral |
| Strength | 50mg |
| Market Status | Prescription |
| Company | Teva; Apotex; Sandoz; Mylan |
| 8 of 8 | |
|---|---|
| Drug Name | Zipsor |
| PubMed Health | Diclofenac |
| Drug Classes | Analgesic, Anti-Inflammatory, Antimigraine, Antirheumatic, Central Nervous System Agent, Musculoskeletal Agent, Ophthalmologic Agent |
| Drug Label | Zipsor (diclofenac potassium) Liquid Filled Capsule is a benzeneacetic acid derivative NSAID. Zipsor is available as liquid-filled capsules of 25 mg for oral administration. The chemical name is 2-[(2,6- dichlorophenyl) amino] benzeneacetic acid mono... |
| Active Ingredient | Diclofenac potassium |
| Dosage Form | Capsule |
| Route | Oral |
| Strength | 25mg |
| Market Status | Prescription |
| Company | Depomed |
Anti-Inflammatory Agents, Non-Steroidal
Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects. (See all compounds classified as Anti-Inflammatory Agents, Non-Steroidal.)
Cyclooxygenase Inhibitors
Compounds or agents that combine with cyclooxygenase (PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES) and thereby prevent its substrate-enzyme combination with arachidonic acid and the formation of eicosanoids, prostaglandins, and thromboxanes. (See all compounds classified as Cyclooxygenase Inhibitors.)
GDUFA
DMF Review : Complete
Rev. Date : 2017-10-27
Pay. Date : 2017-10-16
DMF Number : 23028
Submission : 2009-08-12
Status : Active
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13934
Submission : 1999-01-08
Status : Inactive
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 11990
Submission : 1996-06-06
Status : Inactive
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 12217
Submission : 1996-11-14
Status : Inactive
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 13045
Submission : 1998-06-26
Status : Active
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 12021
Submission : 1996-06-27
Status : Inactive
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 30515
Submission : 2016-04-21
Status : Active
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 15074
Submission : 2000-10-02
Status : Active
Type : II

GDUFA
DMF Review : Complete
Rev. Date : 2013-10-04
Pay. Date : 2013-09-30
DMF Number : 11267
Submission : 1994-12-23
Status : Active
Type : II

GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 12656
Submission : 1997-09-10
Status : Active
Type : II

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Certificate Number : R1-CEP 2007-144 - Rev 01
Status : Valid
Issue Date : 2022-06-17
Type : Chemical
Substance Number : 1508

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Certificate Number : R0-CEP 2002-085 - Rev 01
Status : Withdrawn by Holder
Issue Date : 2004-11-02
Type : Chemical
Substance Number : 1508

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Certificate Number : CEP 2014-031 - Rev 01
Status : Valid
Issue Date : 2025-10-22
Type : Chemical
Substance Number : 1508

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Certificate Number : CEP 2021-137 - Rev 01
Status : Valid
Issue Date : 2024-05-06
Type : Chemical
Substance Number : 1508

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Certificate Number : R0-CEP 2010-133 - Rev 01
Status : Withdrawn by Holder
Issue Date : 2013-10-03
Type : Chemical
Substance Number : 1508

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Certificate Number : CEP 2010-286 - Rev 05
Status : Valid
Issue Date : 2025-03-21
Type : Chemical
Substance Number : 1508

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] Diclofenac Potassium BP/EP/USP
Date of Issue : 2025-12-24
Valid Till : 2028-07-02
Written Confirmation Number : WC-0250
Address of the Firm : Plot No. G-60, MIDC Tarapur,Tal: Palghar, Dist. Thane,\\r\\nMIDC Tarapur Boisar ...

Diclofenac Potassium BP/IP/USP/Ph.Eur.
Date of Issue : 2025-08-26
Valid Till : 2028-08-25
Written Confirmation Number : WC-0134
Address of the Firm : (A Division of Umedica Laboratories Pvt. Ltd.)Plot no. 322/4, 40 Shed Area, G.I....

Date of Issue : 2022-09-30
Valid Till : 2025-08-08
Written Confirmation Number : WC-0066
Address of the Firm : Plot No 1, Hetero Infrastructure SEZ Ltd., N. Narasapuram, Anakapalli -531081, A...

Diclofenac Potassium BP/EP/USP
Date of Issue : 2025-08-26
Valid Till : 2028-08-25
Written Confirmation Number : WC-0076
Address of the Firm : Plot No.5, Phase-IV, G.I.D.C, Industrial Area, Panoli-394116, Dist-Bharuch, Guja...

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Registrant Name : Hana Pharmaceutical Co., Ltd.
Registration Date : 2013-06-14
Registration Number : 20130614-80-D-128-18
Manufacturer Name : Hana Pharmaceutical Co., Ltd...
Manufacturer Address : 133, Jeyakgongdan 3-gil, Hyangnam-eup, Hwaseong-si, Gyeonggi-do @ 78, Jeyakgongdan 4-...

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]NDC Package Code : 62512-0048
Start Marketing Date : 1998-08-06
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT

NDC Package Code : 58747-0450
Start Marketing Date : 1994-01-01
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT

NDC Package Code : 46438-0058
Start Marketing Date : 1999-06-08
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT

NDC Package Code : 48589-0004
Start Marketing Date : 2009-11-04
End Marketing Date : 2027-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT

NDC Package Code : 52935-0016
Start Marketing Date : 1994-03-24
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT

NDC Package Code : 17337-0408
Start Marketing Date : 2017-04-06
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT

Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.
About the Company : Established in 2004, Metrochem API is one of the fastest-growing APIs, pellets & intermediates manufacturers. It has 6 dedicated manufacturing facilities for its 3 core product gro...
About the Company : Jai Radhe Sales, founded in 1999, is a global distributor specializing in high-quality pharmaceutical ingredients from India. It offers complete sourcing solutions, technical and r...
Octavius Pharma has been empowering lives since 1980 by providing quality products like DC granules, APIs and FDFs.
About the Company : Octavius Pharma is a global leader in Directly Compressible Granules with over 45 years of experience in formulation development, manufacturing, and commercialization. Its portfoli...
Tenatra connects Indian manufacturers with global buyers through active partners in Germany, Switzerland, Belgium, Spain & Turkey.
About the Company : Tenatra International was established as a proprietorship firm in 1999. It got off to a very good start, supporting clients in the United States, Mexico and Europe. As business opp...
About the Company : Atom pharma is ISO 9001:2015 integrated, fastest growing and reputed Pharmaceutical bulk drugs [API] and pharmaceutical Intermediates exporting company. We have the industry’s br...

About the Company : Atomgrid is a global company that specializes in the manufacturing and sourcing of specialty chemicals. The company manages end-to-end manufacturing and sourcing needs, covering R&...

About the Company : Established in 1976, J.B.Chemicals & Pharmaceuticals Ltd. (JBCPL) is one of India’s fastest growing pharmaceutical companies. An integrated, research-oriented, public listed orga...

About the Company : Public health is always an imperative that implies immense responsibility, not a mere re-adjustable option. As a company operating under world’s second largest industry of Pharma...

About the Company : Pellsys Pharma drives a new era of Value based Pharmaceutical deliverables. It is well recognized that several explicit, transparent, and consistent Production Standards including ...

About the Company : RA Chem Pharma Limited is a vertically integrated pharmaceutical company.Over the past 10 years, it has expanded its spectrum by establishing state-of-the-art manufacturing facilit...

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ANALYTICAL
ABOUT THIS PAGE
45
PharmaCompass offers a list of Diclofenac Potassium API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Diclofenac Potassium manufacturer or Diclofenac Potassium supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Diclofenac Potassium manufacturer or Diclofenac Potassium supplier.
A Cataflam (TN) manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Cataflam (TN), including repackagers and relabelers. The FDA regulates Cataflam (TN) manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Cataflam (TN) API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Cataflam (TN) manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Cataflam (TN) supplier is an individual or a company that provides Cataflam (TN) active pharmaceutical ingredient (API) or Cataflam (TN) finished formulations upon request. The Cataflam (TN) suppliers may include Cataflam (TN) API manufacturers, exporters, distributors and traders.
click here to find a list of Cataflam (TN) suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
A Cataflam (TN) DMF (Drug Master File) is a document detailing the whole manufacturing process of Cataflam (TN) active pharmaceutical ingredient (API) in detail. Different forms of Cataflam (TN) DMFs exist exist since differing nations have different regulations, such as Cataflam (TN) USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Cataflam (TN) DMF submitted to regulatory agencies in the US is known as a USDMF. Cataflam (TN) USDMF includes data on Cataflam (TN)'s chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Cataflam (TN) USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Cataflam (TN) suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Cataflam (TN) Drug Master File in Korea (Cataflam (TN) KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Cataflam (TN). The MFDS reviews the Cataflam (TN) KDMF as part of the drug registration process and uses the information provided in the Cataflam (TN) KDMF to evaluate the safety and efficacy of the drug.
After submitting a Cataflam (TN) KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Cataflam (TN) API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Cataflam (TN) suppliers with KDMF on PharmaCompass.
A Cataflam (TN) CEP of the European Pharmacopoeia monograph is often referred to as a Cataflam (TN) Certificate of Suitability (COS). The purpose of a Cataflam (TN) CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Cataflam (TN) EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Cataflam (TN) to their clients by showing that a Cataflam (TN) CEP has been issued for it. The manufacturer submits a Cataflam (TN) CEP (COS) as part of the market authorization procedure, and it takes on the role of a Cataflam (TN) CEP holder for the record. Additionally, the data presented in the Cataflam (TN) CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Cataflam (TN) DMF.
A Cataflam (TN) CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Cataflam (TN) CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Cataflam (TN) suppliers with CEP (COS) on PharmaCompass.
A Cataflam (TN) written confirmation (Cataflam (TN) WC) is an official document issued by a regulatory agency to a Cataflam (TN) manufacturer, verifying that the manufacturing facility of a Cataflam (TN) active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Cataflam (TN) APIs or Cataflam (TN) finished pharmaceutical products to another nation, regulatory agencies frequently require a Cataflam (TN) WC (written confirmation) as part of the regulatory process.
click here to find a list of Cataflam (TN) suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Cataflam (TN) as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Cataflam (TN) API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Cataflam (TN) as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Cataflam (TN) and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Cataflam (TN) NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Cataflam (TN) suppliers with NDC on PharmaCompass.
Cataflam (TN) Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Cataflam (TN) GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Cataflam (TN) GMP manufacturer or Cataflam (TN) GMP API supplier for your needs.
A Cataflam (TN) CoA (Certificate of Analysis) is a formal document that attests to Cataflam (TN)'s compliance with Cataflam (TN) specifications and serves as a tool for batch-level quality control.
Cataflam (TN) CoA mostly includes findings from lab analyses of a specific batch. For each Cataflam (TN) CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Cataflam (TN) may be tested according to a variety of international standards, such as European Pharmacopoeia (Cataflam (TN) EP), Cataflam (TN) JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Cataflam (TN) USP).